Dr. Peter McCullough On The AMA And JAMA’s Underpowered Ivermectin Study
“There’s a signal of benefit based on over 70 studies and over 33 randomized trials where there is about a 56% benefit….When someone pitches in a 500 patient trial, and then it’s not blinded, no pla
Original source: https://rumble.com/vvm1aa-dr.-peter-mccullough-on-the-ama-and-jamas-underpowered-ivermectin-study.html
